Max Robotics — Global Service Robot Directory + US Certification

About

Olamide Omidele is a urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques, particularly in robotic-assisted procedures for kidney cancer, prostate disease, and bladder cancer. His major contributions include defining the learning curve for robotic partial nephrectomy through "trifecta" outcomes—a composite measure of no complications, negative margins, and warm ischemia time ≤25 minutes—a study that has garnered 29 citations and become a benchmark for surgical training. He has also pioneered nonopioid pain management protocols following radical cystectomy (16 citations), significantly improving postoperative recovery and reducing opioid dependence. Omidele’s comparative analyses of robotic versus open simple prostatectomy, using statewide New York data (12 citations), have informed surgical decision-making and highlighted the benefits of robotic approaches. His recent work on Aquablation for benign prostatic hyperplasia (9 citations) provides real-world, long-term outcomes from the largest single-center study to date. Additionally, his research on antibiogram-directed prophylaxis to reduce infections after cystectomy (6 citations) and his examination of fellowship training’s impact on robotic partial nephrectomy outcomes (6 citations) underscore his commitment to improving surgical quality and patient safety. With over 80 total citations, Omidele is shaping the future of urologic surgery through evidence-based innovation.